Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Full Copy of the Case Against Concordia, Thompson & Saldanha
View:
Post by GenericAdvocate on Aug 22, 2016 4:20pm

Full Copy of the Case Against Concordia, Thompson & Saldanha

You can see the whole 33 pages of the law suit alleging Violations of Securities Laws.
Thompson and Sladanha are also named as defendants in the law suit.
https://www.whafh.com/case/concordia-international-corp-nasdaq-cxrx-and-tsx-cxr/Interesting!
Comment by visionaryfool on Aug 22, 2016 4:49pm
Love the last page.. Total quantity bought... 210 shares at arrpox. $24USD...w...t...f..? I didn't know you could sue if you had that little on the line.
Comment by MustardTiger88 on Aug 22, 2016 5:06pm
I can't seem to get a straight answer so I'm trying again.  I own CXR, not CXRX.  Are these firms also representing Canadians who own CXR or only those who own CXRX?  I, too, have under 300 shares.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities